Your browser doesn't support javascript.
loading
LCZ696 (sacubitril/valsartan) protects against cyclophosphamide-induced nephrotoxicity in adult male rats: Up-regulation of Apelin-13/ACE2, miR-200, and down-regulation of TGF-ß/SMAD 2/3 and miR-192.
Abbas, Samah S; Schaalan, Mona F; Gebril, Sahar M; Hassan, Fatma E; Mahmoud, Maha O; Hassanin, Soha O.
Afiliación
  • Abbas SS; Pharmacology and Toxicology Department, Faculty of Pharmacy, Misr International University (MIU), Cairo, Egypt. Electronic address: samah.saeed@miuegypt.edu.eg.
  • Schaalan MF; Pharmacy Practice and Clinical Pharmacy Department, Faculty of Pharmacy, Misr International University (MIU), Cairo, Egypt. Electronic address: mona.schaalan@miuegypt.edu.eg.
  • Gebril SM; Histology Department, Faculty of Medicine, Sohag University, Sohag, Egypt. Electronic address: Sahermohamed@med.sohag.edu.eg.
  • Hassan FE; Medical Physiology Department, Kasr Alainy, Faculty of Medicine, Cairo University, Cairo, Egypt; Department of Physiology, Medicine Program, Batterjee Medical College, Jeddah 21442, Saudi Arabia. Electronic address: fatma.e.elsayed@kasralainy.edu.eg.
  • Mahmoud MO; Biochemistry Department, Faculty of Pharmacy, Egyptian Russian University, Cairo, Egypt. Electronic address: Dr_mahamahmoud@hotmail.com.
  • Hassanin SO; Biochemistry Department, Faculty of Pharmacy, Modern University for Technology and Information (MTI), Cairo, Egypt. Electronic address: Soha.hassanin@pharm.mti.edu.eg.
Life Sci ; 306: 120850, 2022 Oct 01.
Article en En | MEDLINE | ID: mdl-35917938
BACKGROUND: Cyclophosphamide (CP) is a widely used chemotherapeutic drug. However, the associated nephrotoxicity restricts its clinical use. AIM: The present research was designed to study the impact of LCZ696 (LCZ); which is a combination of Sacubitril/Valsartan compared to valsartan (VAL) on CP-induced nephrotoxicity. MAIN METHODS: Sixty adult male Wistar rats were randomly and equally assigned into 6 groups as follows: Control, LCZ (30 mg/kg, p.o.), VAL (15 mg/kg, p.o.), CP (200 mg/kg, single dose, i.p.), CP/LCZ, and CP/VAL groups. LCZ and VAL were given once daily for 6 days prior to CP (groups 5 & 6). At the end of the experiment, kidney functions, oxidants/antioxidants, inflammatory and fibrotic biomarkers in renal tissues were assessed. Further, immunohistochemical, and histomorphometric analyses were carried out. KEY FINDINGS: In comparison with CP-treated rats, LCZ resulted in a significant reduction in serum urea (26.6 %) and creatinine (63 %), moreover it decreased renal content of reactive oxygen species (ROS), zinc finger E-box-binding homeobox (ZEB)-1, SMAD2/3, plasminogen activator inhibitor (PAI)-1, fibronectin, histone deacetylase (HDAC)-4, nuclear factor-kappa B (NF-κB) and miR-192 expression by ~40-60 % as well as the immunohistological expressions of transforming growth factor-ß (TGF-ß) and anti-phospho Histone (H2AX) by ~75 % reduction. Whereas the renal total antioxidant capacity (TAC), apelin-13, miR-200 expression, and the immunoreactivity of angiotensin-converting enzyme 2 (ACE2) were enhanced by ~3-4-folds. Noteworthy, the prophylactic effect of LCZ was superior to VAL on the histomorphometric and immunohistological levels. SIGNIFICANCE: Prophylactic administration of LCZ protected against CP-induced nephrotoxicity via up-regulating apelin-13/ACE2, miR-200, and down-regulating TGF-ß/SMAD 2/3 and miR-192.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: MicroARNs / Enzima Convertidora de Angiotensina 2 Límite: Animals Idioma: En Revista: Life Sci Año: 2022 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: MicroARNs / Enzima Convertidora de Angiotensina 2 Límite: Animals Idioma: En Revista: Life Sci Año: 2022 Tipo del documento: Article Pais de publicación: Países Bajos